Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Report Scope

The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.

This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024–2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.

This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.

The report's goals include:

Analyzing product types and applications.

Analyzing global market size and segmentation.

Understanding market constraints and drivers.

Providing detailed market forecasts up to 2029.

Assessing market shares, competitiveness, and industry structure.

Identifying potential long-term impacts on the market.

Report Includes

45 data tables and 52 additional tables

An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry

Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region

Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market

Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds

Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry

Review of selected patents and patent applications on organoids, and emerging developments in the global market

Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies

A discussion of ESG challenges and practices in the industry

Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.

Companies Mentioned

3D BIOTEK LLC.
BIO-TECHNE
CELLINK
CHARLES RIVER LABORATORIES
CHERRY BIOTECH
CORNING INC.
EMULATE
GENOWAY
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
MATTEK
MIMETAS B.V.
PEPGEL LLC.
POIETIS
TACONIC BIOSCIENCES INC.
THEWELL BIOSCIENCE INC.
THERMO FISHER SCIENTIFIC INC.